Each week, we answer "frequently asked questions" about life during the coronavirus crisis. If you have a question you'd like us to consider for a future post, email us at goatsandsoda@npr.org with the subject line: "Weekly Coronavirus Questions."

OK, so I'd planned a flight to visit my grandkids last week because with cold weather and the flu season looming in the U.S., it seemed like late summer/early fall might be a good window of opportunity to travel.

Guatemalan President Alejandro Giammattei said Friday he's tested positive for the coronavirus. Giammattei made the announcement to Sonora, a local radio station.

He said he feels well, is showing typical symptoms of high fever and body aches and has been treated at the Centro Medico Militar, one of the hospitals designated to treat COVID-19 patients in Guatemala City.

President Trump on Friday said "every American" will have a vaccine for the coronavirus available by April, escalating already ambitious goals to fast-track a vaccine for the virus that has killed nearly 200,000 people in the United States.

Puerto Rico is being promised nearly $13 billion in federal disaster funding to repair its electrical and education infrastructure three years after Hurricane Maria's devastation and six weeks before the presidential election.

The Federal Emergency Management Agency plans to award two separate grants to help rebuild Puerto Rico's electrical grid system and educational facilities, the White House announced Friday.

Updated at 6:05 p.m. ET

Hurricane season, like many other aspects of life, has reached peak 2020.

When Tropical Storm Wilfred and Subtropical Storm Alpha formed on Friday, they became the 21^st and 22^nd named storms of the season. Not long after them, weather forecasters spotted Tropical Storm Beta.

If the coronavirus vaccines currently being tested don't pan out, don't expect new drugs to fill the gap any time soon.

Many drugs are in the works, and those that succeed could play a role in reducing symptoms and sometimes saving lives. But, given the way drugs are developed, it's unlikely that any single medicine will be anywhere as potent against the coronavirus as a successful vaccine.